Japan’s machinery orders rebounded strongly in June, which signals that companies led by committed founders are still investing for the future instead of just cutting back. That matters for investors who want leaders with skin in the game, not hired managers focused on the next quarter. This article looks at three founder led stocks from our screener that show how this mindset can help build lasting business legacies.

The three stocks below are just a starting sample, as the full founder led screen surfaced 348 more companies with equally compelling narratives that are not covered here.

If you want to identify the founder led businesses that best fit your style and goals, go straight to the Founder-Led Companies screener.

Dutch Bros (BROS)

Overview: Dutch Bros is a founder-led US coffee chain that operates and franchises drive-thru shops, serving branded coffee, specialty drinks and Rebel energy beverages that reflect its original founder vision. The business is built around high throughput drive-thru formats rather than sit down cafes, which keeps founder focus squarely on operational execution and customer service at scale.

Operations: Dutch Bros generates about US$1.7b from company-operated shops and about US$141 million from franchising and other revenue, with all reported revenue of roughly US$1.9b coming from the United States.

Market Cap: US$9.1b

Investors looking for founder-led growth stories may find Dutch Bros interesting because its co founder heritage still shapes a very focused drive thru model. The business is scaling through new shops, digital rewards and menu extensions such as energy drinks and food pilots. Recent results show solid revenue, positive same store sales and raised full year guidance. Deals such as the planned conversion of up to 65 Salad and Go sites point to an active pipeline of future locations. At the same time, a rich valuation, higher leverage, insider selling and a rapid expansion plan mean the story depends heavily on continued execution by leadership.

Dutch Bros is scaling fast on founder-led execution, digital rewards and new formats. To see how that growth story lines up with valuation, cash flows and balance sheet detail, review the analysis report for Dutch Bros

Build your own founder-led shortlist

Dutch Bros and the other two founder-led stocks here all came from a single screen, but the real value is creating filters around what matters most to you. Use our flexible Screener to mix factors such as valuation, future growth, quality and balance sheet strength, or tap into our curated Investing Ideas for ready-made starting points.

BioNTech (BNTX)

Overview: BioNTech is a German biotech company focused on mRNA vaccines and cancer immunotherapies, led by founders Uğur Şahin and Özlem Türeci. Their work on the COVID-19 vaccine BNT162 and a growing oncology pipeline, including drugs like Pumitamig, Gotistobart and BNT113, anchors its connection to the founder-led theme even as the business broadens beyond pandemic products.

Operations: BioNTech currently generates about €2.7b in revenue from its Pharmaceuticals segment.

Market Cap: US$23.3b

BioNTech interests founder-led investors because the same team that built BNT162 is now redirecting the mRNA and oncology platform toward a broader cancer and infectious disease portfolio, with late stage programs like Pumitamig and Gotistobart beginning to define the next chapter. The trade off is clear. Founders are still heavily involved in capital allocation and science direction, yet the company is in a loss making, investment heavy phase and revenue outside COVID-19 remains limited. If the oncology readouts and partnerships start to validate that pipeline, today’s combination of a sizable cash generating vaccine heritage and a deep cancer franchise in progress could represent a turning point in a long founder driven legacy.

BioNTech’s COVID cash engine is already shifting toward oncology, and the real story could be how that transition unfolds next. Get the full context in the analyst forecasts for BioNTech

Cerebras Systems (CBRS)

Overview: Cerebras Systems is a founder-led AI infrastructure company that builds wafer-scale chips and full rack systems so customers can run large AI models at very high speed. Founder CEO Andrew Feldman’s vision shows up directly in the Wafer-Scale Engine and CS rack platforms, which form the core of its AI compute business rather than a side project.

Operations: Cerebras currently generates about US$680.7 million in revenue from semiconductors, with roughly US$236.6 million from the United States and US$443.5 million from Europe, the Middle East and Africa.

Market Cap: US$52.3b

Investors drawn to founder-led stories may see Cerebras Systems as a way to back a leadership team tying its personal reputation to a bold focus on AI hardware and cloud inference. The company reports a large forward backlog supported by long-duration deals such as its OpenAI partnership and is rolling out products like the new CS-4 systems, which target faster inference speeds for real-world AI workloads. At the same time, Cerebras remains unprofitable, relies heavily on a few big customers and carries funding and dilution risks, so any appeal of Feldman’s long-term roadmap comes with execution pressure and potential share price volatility.

Cerebras Systems is advancing with AI hardware and long-duration contracts, yet the full risk-reward picture still feels under the radar. Get the context that ties backlog, losses and customer concentration together in the 3 key rewards and 2 important warning signs (1 is major!)

Seeking Fresh Alternatives Before They Fly

Some of the most interesting ideas move from quiet to crowded fast. Spot potential breakouts while they are still under the radar for now and act now.

• Spot fast-moving opportunities in smaller companies before the market catches on by scanning the curated 21 elite penny stocks with strong financials that already show stronger financial footing than most peers.
• Target companies building the picks and shovels for AI momentum by tracking the hand-picked 55 AI infrastructure stocks fueling compute, networking and data capacity while that demand still compounds.
• Follow capital flowing into real assets by reviewing a focused pool of 30 elite gold producer stocks that aim to balance production strength with disciplined balance sheets.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.